title: Antibiotics: what's new?
abstract: In addition to the traditional antibiotic choices for skin and skin structure infections, such as beta-lactams, macrolides, and clindamycin, newer broad-spectrum antibiotics are available to treat resistant pathogens that can cause severe infections. The pharmacologic profiles of 3 newer classes of these antibiotics are reviewed briefly, and the role of these agents in treating skin and skin structure infections is discussed.
authors.affiliation: Cleveland Clinic Foundation, Ohio, USA.
authors.forename: Steven P
authors.initials: SP
authors.lastname: LaRosa
authors.forename: Kenneth J
authors.initials: KJ
authors.lastname: Tomecki
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D024841:Fluoroquinolones / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D023303:Oxazolidinones / Q000494:pharmacology* / Q000627:therapeutic use; D017192:Skin Diseases, Bacterial / Q000188:drug therapy*; D018461:Soft Tissue Infections / Q000188:drug therapy*; D025361:Streptogramins / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D023303:Oxazolidinones; D025361:Streptogramins